These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15752884)

  • 1. Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
    Suh WW; Hillner BE; Pierce LJ; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1054-61. PubMed ID: 15752884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.
    Wang SY; Kuntz K; Tuttle T; Kane R
    Breast Cancer Res Treat; 2010 Nov; 124(2):393-402. PubMed ID: 20848183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ.
    Hayman JA; Kabeto MU; Schipper MJ; Bennett JE; Vicini FA; Pierce LJ
    J Clin Oncol; 2005 Aug; 23(22):5171-7. PubMed ID: 16051959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
    Jiveliouk I; Corn B; Inbar M; Merimsky O
    Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
    Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
    J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
    Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
    Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).
    Konski A; Sherman E; Krahn M; Bremner K; Beck JR; Watkins-Bruner D; Pilepich M
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):788-94. PubMed ID: 16109464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.
    Raldow AC; Sher D; Chen AB; Recht A; Punglia RS
    J Clin Oncol; 2016 Nov; 34(33):3963-3968. PubMed ID: 27621393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
    Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.
    Gold HT; Do HT; Dick AW
    Cancer; 2008 Dec; 113(11):3108-15. PubMed ID: 18932243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
    Jobsen JJ; van der Palen J; Ong F
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
    Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
    J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; van Vugt R; Van Dijck JA; Leer JW; Wobbes T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):703-10. PubMed ID: 17544591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.